Could stem cells help stroke patients recover? new trial begins

NCT ID NCT06129175

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether umbilical cord stem cells (Neuroncell-EX) can improve recovery in people who recently had a moderate to severe stroke. Eighty participants will receive either the stem cells or a placebo, plus standard care. The goal is to see if the treatment helps with daily functioning and reduces disability over one year.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
umbilical cord mesenchymal stem cells (Neuroncell-EX)
What this could lead to
If it works, this could point toward a new treatment to improve functional recovery after a stroke, helping patients regain independence.
What could go wrong
This is an early-to-mid-stage trial with only 80 participants, so results may not be conclusive. Stem cell therapies also carry risks like infusion reactions or unknown long-term effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hospital Canselor Tuanku Muhriz UKM

    RECRUITING

    Cheras, Kuala Lumpur, 56000, Malaysia

More trials for these conditions

Other studies related to the condition(s) this trial covers.